Pfenex And Alvogen May Face Delay In Teriparatide Equivalence Rating

Delayed
Obtaining a therapeutic equivalence rating for Pfenex' hybrid teriparatide device in the US could be delayed by a lack of FDA feedback on a study protocol • Source: Shutterstock

More from Value Added Medicines

More from Products